You just read:

INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell™ System for Use in the Treatment of Infertility

News provided by

INVO Bioscience, Inc.

Jan 14, 2019, 08:00 ET